Mumbai: Glenmark Generics Inc, USA, the subsidiary of Glenmark Generics, has been granted final approval from the United States Food and Drug Administration for its abbreviated new drug application (ANDA) for fluocinonide cream, a skin infection ... India Brand Equity Foundation, 2 months ago
7/15/14 - United States : GLENMARK gets final ANDA approval from US FDA for Fluocinonide Cream [TendersInfo (India)] - Pharmacy Choice, 2 months ago
Glenmark Generics receives final ANDA approval for Telmisartan Tablets - Money Control, 2 months ago
Case Name: Sanofi-Aventis Deutschland GmBH v. Glenmark Pharms Inc. , 748 F.3d 1354 (Fed. Cir. Apr. 21, 2014) (Circuit Judges Newman, Linn and Wallach presiding; Opinion by Newman) (Appeal from D.N.J., Cavanaugh, J.) Drug Product and ...JD Supra, 1 month ago GLENMARK PHARMACEUTICALS : Gets nod for skin infection cream 4 Traders, 2 months ago GLENMARK GETS NOD FOR SKIN INFECTION CREAM Pharmacy Choice, 2 months ago
Glenmark Pharmaceuticals will launch generic version of anti-hypertension drug telmisartan tablets in the US market following receipt of approval from the country's health regulator. Glenmark Generics Inc., USA a subsidiary of Glenmark Generics Ltd has been ...The Financial Chronicle, 2 months ago Glenmark gets USFDA nod to launch anti-hypertension drug in US Business Line, 2 months ago
The facility will be situated in Monroe, North Carolina, USA The facility will manufacture oral solids, injectables and topicals over a five year period Mumbai, India; July 17, 2014: Glenmark Pharmaceuticals Ltd; a research-driven, global, ...FiercePharmaManufacturing, 1 month ago Glenmark to set up production unit in U.S. The Hindu, 2 months ago Glenmark plans to set up new facility in US Hindu Business Line, 2 months ago Glenmark to set up first manufacturing facility in US Business Standard India, 2 months ago
/PRNewswire/ -- Consolidated Net Profit increased by 43.65 % to Rs. 1848.46 Mn Business Highlights -- India Business grew by 20.87% to Rs. 3,971.59 Mn -- US Business grew by 9.33% to Rs. 4,886.70 Mn -- Rest of World (ROW) Business grew by ...Scottrade, 1 month ago Glenmark net profit surges by 43.7% in Q1 PharmaBiz, 1 month ago
Glenmark Pharma soars on entering Oncology with discovery of IND enabling studies of innovative b...
Glenmark Pharmaceuticals is currently trading at Rs. 736.50, up by 17.05 points or 2.37% from its previous closing of Rs. 719.45 on the BSE. The scrip opened at Rs. 726.00 and has touched a high and low of Rs. 749.05 and Rs. 726.00 respectively.Arihant Capital, 1 month ago Glenmark Pharma enters Oncology with discovery of IND enabling studies of innovative bispecific antibody Indian-Commodity, 1 month ago
Glenmark Pharmaceuticals is currently trading at Rs. 565.95, up by 1.40 points or 0.25% from its previous closing of Rs. 564.55 on the BSE. The scrip opened at Rs. 564.60 and has touched a high and low of Rs. 568.00 and Rs. 558.50 respectively. So ...Arihant Capital, 2 months ago Glenmark Pharma surges on plan to set up new manufacturing facility in US Arihant Capital, 2 months ago
Rx Care New drugs Image courtesy of PharmaJet BioCSL Inc. has begun shipping its seasonal influenza vaccine Afluria for the 2014-2015 flu season. The company plans to deliver about 16.5 million doses of the 2014-2015 formulation, of which ...Drugtopics.com, 2 weeks ago Court Report - September 2014 #4 JD Supra, 1 week ago Court Report - July 2014 #3 JD Supra, 1 month ago
The Bombay Stock Exchange healthcare index of 17 leading pharmaceutical companies has outperformed BSE Sensex of 30 companies during August 2014. BSE healthcare index improved sharply by 8.2 per cent and closed at 13356.87 as compared to12341.28 as ...PharmaBiz, 3 weeks ago
Key benchmark indices dropped as caution prevailed ahead of the release of minutes from the US Federal Reserve's latest meeting. The barometer index, the S&P BSE Sensex, hit its lowest closing level in almost a week. The Sensex shed 106.38 points or ...Business Standard India, 1 month ago
on your WebpageAdd Widget >Get your members hooked!